The global population is seeing substantial shifts due to the increase in average life expectancy. The World Health Organization reports that as of 2020, the number of individuals over 60 surpasses those under 5 worldwide..
In the UK, there are over 11 million people aged 65 and above, a number expected to rise to 13 million, constituting 22% of the population in a decade. This demographic change has drawn attention to often overlooked health issues, particularly in women: osteoporosis and bone fractures.
Globally, over 8.9 million osteoporotic fractures occur annually, equating to one osteoporotic fracture happening every three seconds somewhere in the world.
It impacts more than 200 million women worldwide, with an estimated one in three women over 50 likely to experience an osteoporosis-related fracture at some point. Studies suggest this is a significant cause of morbidity and mortality in women of this age group.
But why does bone health deteriorate with age? Our bones house specialized cells known as osteoblasts that generate new bone tissue. Conversely, osteoclasts are cells at the other end of the skeletal cycle responsible for dissolving old, damaged bone tissue and replacing it with fresh, healthy tissue.
The balance of activity between these cell types is crucial for bone health. Up to the age of 30, osteoblast activity generally exceeds osteoclast activity, resulting in more bone formation than loss. However, as individuals reach 35, osteoclast activity becomes dominant, leading to a gradual decline in bone quality and density.
Most concerning is the rapid decrease in estrogen production in postmenopausal women, which triggers increased osteoclast activity due to reduced osteoblast numbers and extended osteoclast lifespans. This change is believed to contribute to osteoporosis development.
read more:
When a certain level of bone density loss occurs, osteopenia may develop, leading to extremely low bone density and increased fracture risk, potentially progressing to osteoporosis. This condition is often referred to as “bone thinning,” but it results from changes in bone density, microstructure, and quality that compromise bone strength.
Unfortunately, both osteopenia and osteoporosis are typically asymptomatic until a fracture occurs, making diagnosis incidental. Various risk factors may contribute to the development of these conditions, including smoking, thyroid disease, diabetes, and certain medications like steroids.
Preventive measures for bone health should be initiated early. A balanced, calcium-rich diet is crucial, with dairy products serving as primary sources of calcium. Individuals with restricted dairy intake may need calcium supplements, emphasizing the importance of vitamin D production through sunlight exposure or supplementation.
While calcium and vitamin D are essential for bone health, engaging in bone-straining exercises, especially resistance training, can stimulate osteoblast activity, preventing osteoporosis progression. Exercise not only enhances bone mineralization but also improves muscle strength, balance, and posture, reducing the risk of falls and fractures.
For menopausal women, exercising efficacy in promoting bone mineralization hinges on adequate calcium and vitamin D intake, making supplementation vital. Additionally, various medications are available to treat or slow osteoporosis progression, with estrogen therapies recommended for menopausal women, particularly those with premature ovarian insufficiency.
Education and awareness about bone health can significantly impact prevention and proper management of osteoporosis, especially as societies aged. Addressing these issues is crucial as we navigate the future of an aging population.
Source: www.sciencefocus.com
